Envestnet, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share (Tables)

Net Income (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2022

Schedule of Reconciliation of the Numerators and Denominators used in Computing Basic and Diluted Net Income (Loss) per Share Attributable to Common Stockholders

The following table provides the numerators and denominators used in computing basic and diluted net income (loss) per share attributable to Envestnet, Inc.:


	Three Months Ended
	March 31,
			2022		2021

		(in thousands, except share and per share data)







Net income (loss) attributable to Envestnet, Inc. (a)			$	(13,859)	$	14,946
Interest on dilutive Convertible Notes due 2025, net of tax			—		1,252
Net income (loss) attributable to Envestnet, Inc - Diluted (b)			$	(13,859)	$	16,198

Weighted-average common shares outstanding:
Basic (c)			54,903,677		54,208,469
Effect of dilutive shares:
Options to purchase common stock			—		222,387
Unvested restricted stock units			—		562,606
Convertible Notes			—		4,848,044
Warrants			—		76,142
Diluted (d)			54,903,677		59,917,648

Net income (loss) per share attributable to Envestnet, Inc common stock:
Basic (a/c)			$	(0.25)	$	0.28
Diluted (b/d)			$	(0.25)	$	0.27

Schedule of Anti-Dilutive Securities Excluded from Computation of Diluted Earnings per Share

Securities that were anti-dilutive and therefore excluded from the computation of diluted net income (loss) per share were as follows:


	Three Months Ended
	March 31,
			2022	2021
		(in thousands)
Options to purchase common stock			326,300	—
Unvested RSUs and PSUs			2,641,362	—
Warrants			470,000	—
Convertible Notes			9,898,549	5,050,505
Total anti-dilutive securities			13,336,211	5,050,505